The following clinical trials are available at Kettering Health Network as of May 1.
Convalescent Plasma – Mayo Clinic Trial
Eligibility Criteria:
- Age at least 18 years
- Lab confirmed diagnosis of COVID-19
- Hospitalized
- Severe disease or high risk of progression
Remdesivir Expanded Access – Gilead Pharmaceuticals (Only at Kettering Medical Center at this time)
Eligibility Criteria:
- Age at least 12 years old and weighing at least 40kg
- Hospitalized with confirmed Covid-19
- Requiring mechanical ventilation
- ALT < 5x upper limit of normal
- Absence of renal or hepatic failure
Ruxolitinib (IL-6 Inhibitor) Expanded Access – Parexel
Eligibility Criteria:
- 12 years of age or greater
- Diagnosis of Covid-19
- Severe disease – Respiratory rate>24, SpO2 <90% on RA, mechanical ventilation, ARDS, or multiorgan failure
- ALT < 4x upper limit of normal
- PLT >50k
For questions or to enroll a patient, please contact Jeffery Weinstein, MD, at (937) 371-5871 or Jeffrey.Weinstein@ketteringhealth.org or Allison Dymacek at Allison.Dymacek@ketteringhealth.org .